Genesis Therapeutics Stock
Genesis Therapeutics is a biotechnology company pioneering the use of artificial intelligence (AI) for drug discovery and development. Its proprietary platform, GEMS (Genesis Exploration of Molecular Space), employs cutting-edge AI models for predicting molecular properties, designing novel drug candidates, and optimizing existing leads.
Founded: 2019
For more Genesis Therapeutics stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Evan Feinberg, Ph.D. Co-Founder and CEO |
| Ben Sklaroff Co-Founder and CTO |
| Will McCarthy COO |
| Peppi Prasit, Ph.D. Acting CSO |
